Inflammation markers help predict breast cancer survival

05/27/2009 | Boston Globe (tiered subscription model), The

U.S. researchers found breast cancer patients with high levels of C-reactive protein and serum amyloid A, both markers for inflammation, were two to three times more likely to die early or have a recurrence of the disease. Testing for these markers could help determine a woman's prognosis, they said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY